-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Bristol-Myers Squibb, Raises Price Target to $64

Benzinga·07/31/2026 18:40:11
Listen to the news
RBC Capital analyst Trung Huynh maintains Bristol-Myers Squibb (NYSE:BMY) with a Sector Perform and raises the price target from $60 to $64.